Data / Form D filings / SCYNEXIS INC
SCYNEXIS INC: Form D filings
SCYNEXIS INC, a pharmaceuticals company in Durham, NC, filed 3 Form D notices with the SEC between 2011 and 2012. The latest, on May 18, 2012, reports $11.4 million sold of a $15 million offering to 11 investors.
Find out what SCYNEXIS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3501-C TRICENTER BLVD, Durham, NC, 27713
- Phone
- (919) 544-8600
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1178253
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2012 | Amendment | $15,007,500 | $11,449,343 | $3,558,157 | 11 | Dec 7, 2011 | sec.gov |
| Feb 3, 2012 | Amendment | $15,007,500 | $5,724,671 | $9,282,829 | 11 | Dec 7, 2011 | sec.gov |
| Dec 16, 2011 | New notice | $15,007,500 | $5,502,750 | $9,504,750 | 9 | Dec 7, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Pamela J. Kirby | Director | |
| Jean-Yves F. Nothias | Director | |
| Ann F. Hanham | Director | |
| Jose F. Barella | Director | |
| Mounia F. Chaoui | Director | |
| Ed J. Penhoet | Director | |
| Laurent F. Arthaud | Director | |
| Charles F. Osborne, Jr. | Executive Officer | |
| Yves J. Ribeill | Executive Officer, Director | |
| Patrick J. Langlois | Director | |
| Brian J. Schwab | Executive Officer |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of May 14, 2012 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SCYNEXIS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.